Commodity price rises boost ICL’s profit and revenue
Israeli specialty chemical substances company ICL (TASE: ICL: NYSE: ICL), controlled by Idan Ofer, has described incredibly solid effects for the very first quarter of 2022, boosted by the bounce in commodity prices worldwide. The organization has also elevated its assistance for 2022.

ICL’s profits in the first quarter of 2022 was $2.525 billion, up 67% from $1.510 billion in the corresponding quarter of 2021. Internet profit in the initially quarter of 2022 was $632 million, up 368% from the 1st quarter of 2021. Modified EBITDA of $1.002 billion was up 232% from $302 million in the 1st quarter of 2021.




Similar Articles or blog posts




Israel Corp. sells ICL shares for $220m



ICL gets most useful TASE business



Sanctions on Belarus to enhance ICL potash sales



ICL signs larger-priced Chinese potash agreements







ICL president and CEO Raviv Zoller stated, “ICL delivered history benefits, even with global uncertainty, and leveraged its agility and range in the confront of continuing provide chain challenges. Once all over again, all our specialty organizations realized new quarterly results data, as all 4 of our divisions contributed to our sizeable development and new ICL document product sales and EBITDA.

He added, “We continued to emphasis on lengthy time period money technology by innovating in our specialty businesses item portfolio and by driving value efficiencies. The disruptions brought about by the pandemic, sanctions and the conflict in Ukraine have radically shifted market place dynamics and could go on to appreciably affect international agriculture, food and industrial marketplaces in the in the vicinity of expression. We will go on to enhance our consumer and provider relationships, to handle by way of world source challenges and to perform to guarantee constant and reliable item provide for our consumers.”

ICL stated that due to the very potent benefits in the 1st quarter, and significant changes in sector dynamics, the organization is raising its expectations for entire year modified EBITDA to a selection of $3.5 billion to $3.750 billion, with between $1.300 billion to $1.400 billion coming from its specialties targeted organizations.

ICL’s share cost rose 2.60% to $10.26 on Wall Road previous night time, offering a market cap of $13.66 billion. The share price tag is up a additional 2.34% in premarket buying and selling.

Posted by Globes, Israel enterprise news – en.globes.co.il – on May well 11, 2022.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2022.